The Oswald Avery Award for Early Achievement recognizes outstanding achievement in an area of infectious diseases by an individual member or fellow of IDSA who is 45 or younger (on December 31 of the year preceding the IDWeek at which the award is given). The award is based on overall achievement, not usually a single study.
Nominations
Nominees for the Oswald Avery Award for Early Achievement must be 45 or younger. Please take a moment to review the nomination application and ensure that an NIH biosketch is available to upload as a part of the nominations package.
2021 Winner: Michail Lionakis, MD, ScD, FIDSA
Michail Lionakis, MD, ScD, FIDSA, a clinical investigator who has made multiple breakthroughs in fungal pathogenesis, is the recipient of IDSA’s 2021 Oswald Avery Award for Early Achievement. This honor recognizes members or fellows of IDSA age 45 or younger who have demonstrated outstanding achievements in an area of infectious diseases.
An outstanding physician-scientist, Dr. Lionakis is a senior investigator at the National Institute of Allergy and Infectious Diseases at the National Institutes of Health, where he is also chief of the Fungal Pathogenesis Section and deputy chief of the Laboratory of Clinical Immunology and Microbiology. His research has identified novel genetic and immunologic factors that can explain susceptibility to fungal infections. This has included delineating the roles of CX3CR1, CCR1, CXCR1 and CARD9 in Candida pathogenesis in mice. These findings have important implications for Candida infection, for understanding innate immunity and for developing innovative therapies.
Dr. Lionakis’s work has also identified interferonopathy as the critical driver of mucosal candidiasis in patients with autoimmune polyendocrinopathy-candidiasis-ectodermal dystrophy. More recently, recognizing the need for novel approaches to the management of COVID-19, he has also provided leadership to a group assessing the inhibition of BTK-dependent NF-kB and inflammasome activation in macrophages on the progression of COVID-19. This work formed the basis for phase II and III trials of acalabrutinib.
The author of more than 160 articles in peer-reviewed publications and a global leader in his field, Dr. Lionakis has built a clinical program at NIH that is a magnet for young investigators and is rapidly expanding its scope and accomplishments. He has served on multiple committees at NIH and elsewhere and has received several honors, including the NIH Director’s Award and the NIAID Merit Award. IDSA is pleased to recognize him with the 2021 Oswald Avery Award for Early Achievement.
Past Oswald Avery Award Winners
2020 | Sallie R. Permar, MD, PhD |
2019 | Nasia Safdar, MD, MS, PhD, FIDSA, FSHEA |
2018 | Susanna Naggie, MD, MHS, FIDSA |
2017 | William J. Steinbach, MD |
2016 | Susan S. Huang, MD, MPH, FIDSA, FSHEA |
2015 | Eric R. Houpt, MD, FIDSA |
2014 | Sarah E. Cosgrove, MD, MS, FIDSA, FSHEA and Rochelle P. Walensky, MD, MPH, FIDSA |
2013 | Cesar A. Arias, MD, MSc, PhD, FIDSA |
2012 | Dan A. Barouch, MD, PhD |
2011 | Umesh Parashar, MBBS, MPH |
2010 | Eleftherios Mylonakis, MD, PhD, FIDSA |
2009 | Jean-Laurent Casanova, MD, PHD |
2008 | Vance G. Fowler, Jr., MD, MHS |
2007 | Pablo C. Okhuysen, MD, FIDSA |
2006 | Cynthia G. Whitney, MD, MPH |
2005 | James E. Crowe, MD |
2004 | B. Brett Finlay, PhD |
2003 | Joseph Heitman, MD, PhD |
2002 | Matthew K. Waldor, MD, PhD |
2001 | David A. Relman, MD |
2000 | Michael S. Donnenberg, MD |
1999 | William A. Petri, Jr., MD, PhD |
1998 | Joseph W. St. Geme, III, MD |
1997 | Samuel I. Miller, MD |
1996 | David D. Ho, MD |
1995 | Michael Osterholm, PhD, MPH |
1994 | Mark Klempner, MD |
1993 | Claire Broome, MD |
1992 | Martin Blaser, MD |
1991 | Marcus Horwitz, M.D. |
1990 | Jerrold Ellner, MD |
1989 | Henry Murray, MD |
1988 | Walter Stamm, MD |
1987 | John Gallin, MD |
1986 | Charles Dinarello, MD |
1985 | Dennis Kasper, MD |
1984 | Adel Mahmoud, MD, PhD |
1983 | Anthony Fauci, MD |
1982 | George Miller, PhD |
1981 | Gerald Keusch, MD |
1980 | Robert Purcell, MD |
1979 | Stanley Falkow, PhD |
1978 | King Holmes, MD, PhD |
1977 | Lowell Glasgow, MD, MS |
1976 | Sheldon Wolff, MD |
1975 | Kenneth Warren, MD |
1974 | Malcolm Artenstein, MD and Emil Gotschilch, MD |
1973 | Frank Austen, MD |
1972 | Zanvil Cohn, MD |
1971 | Jonathan Uhr, MD |
1970 | Hans Mueller-Eberhard, MD, DMSc |
1969 | Robert Chancock, MD |
1968 | Robert Good, MD, PhD |